Category: Workers Comp

523 posts found

The Top Priorities of the Workers’ Comp Industry for Future Resiliency

The initial results from a collaborative survey between Healthe and Risk & Insurance.®

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

New five-day rules are recommended, with variation depending upon vaccination status.

The Bureau of Labor Statistics reports that 4.5 million employees quit their jobs in November 2021.

Healthe’s SVP of Product Strategy and Innovation, Kristine Kennedy, discusses this topic with Risk & Insurance magazine.

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Those previously infected by the virus may face long-term health complications.

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.

Rulings from U.S. District Courts have impeded vaccine requirements among certain workers.

All adults may now receive a booster shot of any COVID-19 vaccine.

A new naloxone drug and a new opioid-NSAID combination.

Strategies for a safer, healthier workforce amid COVID-19 and beyond.

All COVID-19 vaccines now have emergency use authorization for a booster dose.

One-third of employees have witnessed cannabis use during work hours.

Pre-pandemic, 951 claims received telemedicine, jumping to 21,000 during the pandemic.

Prev 1 2 3 4 5 … 15 16 17 18 19 … 31 32 33 34 35 Next